Legend:

• Concept Types
  • target (clinical findings)
  • classification term
  • pathway-based classification term
  • clinical findings
  • multiple types disease
  • single disease
  • disease type

'Blindness'  (Integration tree)

Pathogenesis

• Genetic disorders of glycan degradation

Disorders by systems

• Genetic disorders of glycan degradation (by systems, signs and symptoms)
  • Diseases
    • Nervous System Diseases
      • Neurologic Manifestations
        • Sensation Disorders
          • Vision Disorders
            • Blindness
              • Schindler disease, type I (GDGDB) [NAGA]
              • Galactosialidosis (GDGDB) [CTSA]
              • Hurler syndrome (GDGDB) [IDUA]
              • Hurler-Scheie syndrome (GDGDB) [IDUA]
              • Scheie syndrome (GDGDB) [IDUA]
              • Morquio syndrome A (GDGDB) [GALNS]
              • Morquio syndrome B (GDGDB) [GLB1]
              • Mucopolysaccharidosis VI (GDGDB) (GDGDB) [ARSB]
              • Mucopolysaccharidosis VII (GDGDB) [GUSB]
              • GM1-gangliosidosis, type I (GDGDB) [GLB1]
              • GM1-gangliosidosis, type II (GDGDB) [GLB1]
              • GM1-gangliosidosis, type III (GDGDB) [GLB1]
              • Tay-Sachs disease (GDGDB) [HEXA]
              • Sandhoff disease (GDGDB) [HEXB]
              • GM2-gangliosidosis, AB variant (GDGDB) [GM2A]
              • Krabbe disease (GDGDB) [GALC]
              • Metachromatic leukodystrophy (GDGDB) [ARSA]
              • Metachromatic leukodystrophy, due to saposin B deficiency (GDGDB) [PSAP]